top of page
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
- Sat, Jun 07
- Thu, Jun 12Adverse Reaction Identification and Management Considerations ~ CARVYKTI /Davio's Northern Italian Restaurant
- Thu, May 22
- Thu, May 15
- Tue, May 13
Search
AYVAKIT & Indolent Systemic Mastocytosis ~ August 8th @ Grill 23 & Bar
Click here to register.
5 days ago1 min read
66 views
0 comments
Iwilfin (DFMO) Maintenance treatment for High Risk Neuroblastoma ~ May 22nd, 2025
Join us at Joe's On Newbury on May 22nd at 6:30pm for a great review of Iwilfin for High Risk Neuroblastoma
May 41 min read
0 views
0 comments
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
Join other Boston ONS members for another excellent review of CAR-Therapy Adverse Reactions Review! Click here to register!
Apr 151 min read
4 views
0 comments
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
Check out this new event and grab a seat!
Apr 121 min read
2 views
0 comments
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Register and learn more! See attached flyer to share with colleagues and learn more.
Feb 61 min read
9 views
0 comments
Dec 27, 20240 min read
11 views
0 comments
Ovarian Function Suppression in HR+ Premenopausal Advanced Breast Cancer ~ NOW December 18th, 2024
NEW UPDATE! To register, email Trish Ferrier at trish.ferrier@tersera.com .
Nov 26, 20241 min read
21 views
0 comments
LUNCH & LEARN ~ Advanced Systemic Mastocytosis and the APEX Clinical Trial ~ Tuesday, 12/3/24
Hosted by:
Nov 24, 20241 min read
22 views
0 comments
Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th
Click here to learn more and register!
Oct 31, 20241 min read
9 views
0 comments
Oct 8, 20240 min read
11 views
0 comments
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Click here to learn more and register!
Oct 8, 20241 min read
11 views
0 comments
Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd
Click here to register and learn more! Presented by: Tara Graff, DO Mission Blood + Cancer, Des Moines, Iowa
Oct 8, 20241 min read
17 views
0 comments
Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24
Click here to register and learn more! Presented by: Mark Socinski, MD Executive Medical Director AdventHealth Cancer Institute, Orlando,...
Oct 8, 20241 min read
5 views
0 comments
A Step Forward - Initiating VENCLEXTA Treatment in Patients with CLL - October 22nd @ 5:30pm
Click here to learn more and register!
Oct 4, 20241 min read
6 views
0 comments
Diffuse Large B Cell Lymphoma Update ~ LIVE ~ October 22nd, 6-8pm
Join us on Tuesday, October 22nd, from 6-8pm at Joe's On Newbury for a wonderful overview of Diffuse Large B Cell Lymphoma. Presented by...
Sep 29, 20241 min read
12 views
0 comments
A Path Forward in Managing AML - NEW VIRTUAL EVENT - 10/1/24
Register with BONS! Click here
Sep 24, 20241 min read
10 views
0 comments
NEW EVENT! Live presentation on the latest data for Libtayo
REGISTER Check out this upcoming event! Hosted by Regeneron Register today via Boston ONS. More details shared through registration.
Aug 25, 20241 min read
29 views
0 comments
Aug 8, 20240 min read
9 views
0 comments
Understanding AYVAKIT: a treatment option for adults with ISM and AdvSM ~ August 7th, 2024
Presented (on behalf of Blueprint Medicines) by: James McCloskey, MD Chief, Division of Leukemia John Theurer Cancer Center Wednesday,...
Jul 23, 20241 min read
42 views
0 comments
New EVENT! Live tomorrow @ Omni Parker House
Register via email to Sasanka Atapattu at satapatt@its.jnj.com
May 22, 20241 min read
23 views
0 comments
bottom of page